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Background/aim: Breast lesions that are not palpable on physical examination but considered suspicious for malignancy on
mammography or ultrasonography should be marked before surgery. Wire-guided localization (WGL) is the most frequently used
method for preoperative marking of nonpalpable breast lesions (NPBLs). An alternative is marking by a radioactive agent (radio-guided
occult lesion localization; ROLL). The present study aimed to compare WGL and ROLL for preoperative marking.
Materials and methods: The study included 25 patients marked by ROLL and 11 patients marked by WGL. The groups were compared
in terms of patient and lesion characteristics, method-related characteristics, hospital stay duration, complications, cosmetic outcomes,
and rate of correct marking.
Results: Suspicious lesions were marked with a success rate of 95.6% by ROLL and 100% by WGL. Complications and pain sensation
rates were found significantly lower in the ROLL group compared to WGL. Although ROLL was considered more advantageous in terms
of hospital stay duration, positive surgical margins, cosmetic outcomes, and excision duration, the differences between the groups were
not statistically significant.
Conclusion: ROLL, which is a simple, comfortable, and reliable method, could be used as an alternative to the WGL in preoperative
marking of NPBLs.
Key words: Nonpalpable breast lesion, radio-guided occult lesion localization, wire-guided localization, SPECT-CT

1. Introduction
Breast cancer is the leading malignancy among women
and the second leading cause of cancer-related deaths
following lung cancer. The life-time risk of breast cancer
is 12.3% in women and one in each 8 women has the risk
of developing breast cancer. The life-time risk for death
due to breast cancer is 3.6% and it is the leading cause
of cancer deaths among women aged between 40 and 55
years (1). Despite remarkable advances in the treatment of
breast cancer in the recent years, early diagnosis remains
important for obtaining successful therapeutic outcomes.
Breast scanning aims to detect breast cancer as early
as possible. The most common methods used in routine
practice to visualize breast diseases include mammography,
ultrasonography (US), and magnetic resonance imaging
* Correspondence: nbkanat@gmail.com

(2). Lesions that cannot be detected by physical examination
but display asymmetry, microcalcification, and distortion
on scanning methods such as mammography and US are
defined as nonpalpable breast lesions (NPBLs) (3). Along
with widespread implementation of breast screening
programs, prevalence of detecting NPBLs has been
increased in the recent years and it has been demonstrated
that early diagnosis substantially reduces breast cancerrelated mortality and morbidity (4).
Increase in the rate of detecting NPBLs has raised
the need for percutaneous methods for the diagnosis
and treatment of these lesions. Interventional methods
used for the diagnosis of NPBLs include needle biopsy
(mammography or US), preoperative marking, and
excisional biopsy (4,5). Preoperative precise localization
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of NPBLs is important. In the excisional biopsy of NPBLs
detected by various imaging methods, marking under
imaging guidance is mandatory for the surgeon to expose
the lesion and to minimize the loss of normal tissue. In
general, suspicious areas where the marking would be
performed include solid and complex cysts detected on
US, suspicious microcalcifications, and parenchymal
distortions detected by mammography (i.e. usually
BIRADS-4 and BIRADS-5 lesions) (6).
Today, wire-guided localization (WGL) is the most
frequently used marking method (7). In this method, a
wire with a curly end is placed into the suspected lesion
under mammographic and US guidance. Radio-guided
occult lesion localization (ROLL) is another method
alternative to WGL for the marking of NPBLs (8). ROLL
depends on the principle of injecting a radioactive agent
into the microcalcification or suspicious solid lesion
detected by imaging methods under US or mammography
guidance and then excision of the lesion in the surgery
room by gamma probe. Although mostly Tc-99m-MAA
(macroaggregated albumin) is used in the ROLL method,
there are studies reporting the use of compounds such
as Tc-99m-nanocolloid or I-125 titanium as well (9).
For all lesions detected on mammography and marked
before surgery, radiographies of the specimen should be
performed to determine whether the lesion is completely
removed or not. In routine practice, these radiographies
are evaluated by the images obtained by a single projection
of the specimen (10).
The aim of the present study was to compare WGL
and ROLL for preoperative marking of NPBLs in terms
of patient and lesion characteristics, features related to
marking method, hospital stay duration, complications,
cosmetic outcomes, and rate of successful marking, as
well as to investigate the contribution of the use of singlephoton emission computed tomography combined with
computed tomography (SPECT-CT) with surgery for the
localization of lesions in the ROLL group.
2. Materials and methods
The study included 36 female patients (between 24 and
78 years of age) who had NPBLs (<2 cm) and suspicious
findings for malignancy on mammography and breast US
(BIRADS-3, -4, or -5). Pregnant and breastfeeding women
were excluded from the study. Approval of the Hacettepe
University Faculty of Medicine Ethical Committee (LUT
10/69-20) and written informed consent of the patients
were obtained. Patients were randomized into the ROLL
and WGL groups.
In the ROLL group (n = 25), on the morning of surgery
day, intratumoral 0.5 mCi Tc-99m-MAA was injected into
the suspected lesion previously detected by mammography
or US. The method (mammography or US) that was used
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to detect suspicious lesion was assigned by radiologists.
Microcalcification, parenchymal distortion, and focal
asymmetric breast density were marked by mammography,
whereas solid and complex cystic lesions with irregular
margin extending up to spicule were marked by US.
In the WGL group (n=11), on the morning of surgery
day, the previously detected suspicious lesion was marked
by WGL under mammographic or US guidance. Marking
was done prior to the surgery by a radiologist using a
stereotaxic marking apparatus (Seno DS, GE Medical
Systems, Chicago, IL, USA) fixed on the mammography
device or using an US device (Aplio XG, Toshiba Medical
System Corporation, Otawara, Japan). The wire was
pushed through the lesion under imaging guidance.
All the patients marked by ROLL method underwent
planar scanning by gamma camera in the nuclear medicine
department and success of injection and whether there was
contamination or not were checked. In addition to planar
scanning, 12 patients underwent SPECT-CT in the nuclear
medicine department after marking to make a contribution
to the physician. SPECT-CT could be performed for
only 12 patients due to technical difficulties. SPECTCT was performed with a hybrid device composed of a
double-headed gamma camera and integrated 4-section
CT (Hawkeye, GE Medical Systems). CT images were
recorded on a 512 × 512 matrix using 2.5 mA parameters
and at 140 keV energy peak. SPECT images were recorded
on a 128 × 128 matrix with 140 keV energy peak, 10%
interfenestration, and 360°, obtaining a 20 s count in each
pause. Fusion images (axial, coronal, and sagittal) of the
lesions in which radioactive agent uptake was detected
were recorded and printed on films. These films were used
to inform the surgeon in more detail about the localization
of the lesion.
The surgically removed specimen after marking was
put into a container including 10% formaldehyde and
sent to the pathology department. Specimen margins were
stained with India ink in different colors and sliced into
thin sections. The tumor was evaluated macroscopically
for the size of the specimen (width, length, height) and
microscopically for pathological diagnosis of the lesion,
tumor diameter, closeness to the surgical margin, and
estrogen-progesterone receptor status.
The WGL and ROLL groups were compared in terms
of age, body mass index (BMI), radiological findings, pain
during procedure, duration of excision of the lesion, weight
of specimen, positivity of surgical margin, duration of
hospital stay, complications, cosmetic outcomes, and rate
of successful marking. The contribution of SPECT-CT to
the surgery was evaluated for the patients who underwent
SPECT-CT. Pain during the marking procedure was
assessed by visual analog scale (VAS). Excision duration
was recorded as the time between the start of incision and
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the time when the lesion was removed completely. Weight
of the specimen excised under surgery room conditions
was weighed by precision kitchen scale and recorded in
grams. Cosmetic outcomes were obtained by phone call at
the postoperative 1st and 6th months and scored between
1 and 10 (1 = very bad, 10 = excellent). However, patients
with malignant pathology who underwent a second
surgery (5 patients in the ROLL group and 3 patients in
the WGL group) in the early period (before 1 month) were
excluded from the evaluation. Contribution of SPECTCT to the surgeon was evaluated by conferring with the
surgeon prior to the surgery based on the films printed on
axial, coronal, and sagittal planes.
Success of correct marking of the suspicious lesion in
the ROLL group was evaluated in 3 steps. The first step
included the control during the injection of radioactive
agent, in which observing the contrast agent close to the
suspicious lesion following radioactive marking under
mammographic guidance and detecting an increase in
echogenicity during injection of the radioactive agent
into the lesion under US guidance were considered as the
criteria for success. The second step included scintigraphic
control of the patient after the injection of the radioactive
agent, in which the place of injection on planar
scintigraphy taken in the nuclear medicine department
and the presence of contamination were controlled. The
last step included scintigraphic and radiologic control
of the specimen, in which specimens were scanned by
scintigraphy and specimen graph (only those marked
under mammographic guidance) and the marked lesion
was controlled for whether it was correctly removed or not
during the surgery. Scintigraphic control was performed
for all lesions marked under US guidance; however, control
by direct graph was not performed since the lesion had no
sign on direct graph.
In the WGL group, marking success was evaluated
in two steps. The first step included the control during
marking by wire, which was verified by the tip of the
wire being close (<1 cm) to the suspicious lesion for the
lesions marked under mammographic guidance, and by
observing wire echogenicity in the suspicious lesion for
the lesions marked under US guidance. The second step
included radiological control of the specimen, in which
demonstrating the suspicious lesion on a direct graph of
specimens of the patients marked under mammography
was considered as the criterion for success. No radiological
examination was performed for the specimens of the
patients marked under US guidance.
2.1. Statistical analysis
Data were analyzed using SPSS 15.0 for Windows (SPSS
Inc., Chicago, IL, USA). Numerical variables were
expressed as mean ± standard deviation or median
(minimum–maximum), whereas categorical variables

were presented as number and percentage. For the
intergroup comparisons, a t-test was used for independent
groups and the Mann–Whitney U test was used for
numerical variables that did not provide parametric test
assumptions. Fischer’s exact chi-square test was used for
categorical variables in the intergroup comparisons. P <
0.05 was considered significant.
3. Results
The present study evaluated 36 NPBL patients with 25
patients (28 lesions) in the ROLL group and 11 patients
in the WGL group. No significant differences were found
between the groups in terms of age, BMI, scanning method,
and the distribution of BIRADS categories (Table 1).
Radiological findings before marking were evaluated
in both groups. Of the 28 lesions in the ROLL group
marked under mammographic or US guidance, 14
were microcalcification, 10 were solid nodules, 3 were
parenchymal distortions, and one was a cystic lesion.
Of the 11 suspicious lesions marked in the WGL group,
4 were microcalcifications, 2 were solid nodules, 3 were
cystic lesions, one was parenchymal distortion, and one
was hypoechoic mass. In the ROLL group, pathological
results of 66.6% (n = 8) of the lesions that were interpreted
as BIRADS-5 and 25% (n = 1) of the lesions that were
interpreted as BIRADS-3 were malignant. In the WGL
group, pathological results of 66.6% (n = 2) of BIRADS-5
lesions and 62.5% (n = 5) of BIRADS-4 lesions were
malignant. No malignant pathology was detected in
BIRADS-4 lesions in the ROLL group or in BIRADS-3
lesions in the WGL group. Suspicious lesions observed on
mammography and US were mostly located in the upperinner quadrant (n = 5) and upper-outer quadrant (n = 5)
of the right breast in the ROLL group, whereas they were
mostly located in the upper-outer quadrant (n = 5) of the
left breast in the WGL group. Histopathological evaluation
revealed a malignant lesion in 9 (36%) and a benign
lesion in 16 (64%) of the patients in the ROLL group.
Histopathological results were reported as malignant in
7 (63.6%) and benign in 4 (36.4%) of the patients in the
WGL group.
Features related to marking procedure and lesions
are summarized in Table 2. No significant difference
was found between the groups except for VAS score and
complication rates. Pain during the procedure and the
rate of complications were higher in the WGL group
compared to the ROLL group. Complications in the ROLL
group included hematoma in one patient and inadequate
radioactivity injection in one patient. Complications in the
WGL group included postoperative hematoma, surgical
wound infection, arterial bleeding, displaced wire, and
broken wire in one patient each.
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Table 1. General characteristics of the study groups.
ROLL group
(n= 25)

WGL group
(n= 11)

P

Age

47.56 ± 10.61

53.27 ± 10.29

0.143

BMI

36.00 ± 5.54

28.96 ± 5.36

0.683

Mammography

12 (48.0)

5 (45.5)

Ultrasonography

13 (52.0)

6 (54.5)

28 lesions

11 lesions

3

4 (14.3)

-

4

12 (42.9)

8 (72.7)

5

12 (42.9)

3 (27.3)

Scanning method

BIRADS category

1.000

0.818

Data are expressed as mean ± standard deviation or number (%), where appropriate.
ROLL, Radio-guided occult lesion localization; WGL, wire-guided localization; BMI, body mass index.
Table 2. Features related to marking procedure and lesions in the study groups.
ROLL group

WGL group

P

Pain during marking procedure (VAS score)

2.0 ± 0.81

2.61 ± 0.67

0.037

Excision duration of lesion, min

12.61 ± 4.57

13.90 ± 4.72

0.433

Weight of specimen, g

49.78 ± 38.32

39.63 ± 17.03

0.260

Positive

3 (33.3)

3 (42.9)

Negative

6 (66.7)

4 (57.1)

Diameter of malignant lesion, cm

2.23 ± 1.79

1.77 ± 1.69

0.758

Duration of hospital stay, min

290 ± 374

640 ± 1267

0.611

Complication rate

2 (8.0)

5 (45.5)

0.018

Postoperative 1st month

7.71 ± 1.7

5.75 ± 3

0.890

Postoperative 6th month

8.21 ± 1.2

7±1

0.620

Surgical margin of malignant lesions
0.343

Score of cosmetic outcome

Data are expressed as mean ± standard deviation or number (%), where appropriate.
ROLL, Radio-guided occult lesion localization; WGL, wire-guided localization; VAS, visual analog scale.

Considering the criteria for success of correct marking
mentioned in Section 2, the ROLL method was found
successful in 24 (96%) of 25 patients and in 27 (96.4%) of 28
suspicious lesions. In the remaining one patient, increase
in echogenicity during injection was found suspicious
and marking was considered unsuccessful in this patient.
Correct injection of the radioactive agent into the lesion
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area was verified with planar scintigraphy in 24 (96%)
of 25 patients and in 27 (96.4%) of 28 suspicious lesions.
Remarkable uptake, other than minimal radioactivity
uptake, was not observed at the injection site in the
remaining one patient. None of the patients had signs
of contamination. Specimens of two patients were failed
to be transferred to the nuclear medicine department.
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Specimen scintigraphy revealed radioactivity in 22
(95.6%) of 23 patients and in 25 (96.1%) of 26 suspicious
lesions. Radioactivity was not detected in the remaining
one patient. Consequently, the suspicious lesion could be
successfully excised in 96.1% of the lesions. It was found
that the radioactive agent was left in the injector in the
patient whose scintigraphy revealed no radioactivity. In all
patients in the WGL group, the tip of the wire was observed
close to the relevant lesion during marking and the success
rate of marking was considered to be 100%. A suspicious
lesion was detected on the specimen graph of 4 of 5
patients that underwent marking under mammographic
guidance. The specimen of one patient was excluded from
evaluation since it could not be transferred to the radiology
department. As a consequence, the rate of correct marking
was found high in both the WGL and ROLL groups.
It was determined that SPECT-CT made a contribution
to the surgeon for the localization of lesion in 4 (33%) of 12
patients. One of these 4 patients had 2 suspicious lesions
close to each other in the left breast and each lesion had
undergone radioactive agent injection separately. The
remaining 3 patients had lesions with deep localization.
Surgeons were more oriented by getting informed about
the deepness of the lesions via SPECT-CT and the lesions
were excised.
4. Discussion
Along with the use of screening programs (mammography
and US) all over the world, the prevalence of incidental
NPBLs has gradually increased. Early detection of signs
suggestive of malignancy such as focal asymmetry
and mass on mammography substantially reduces the
morbidity and mortality of breast cancer (11). The aim
of marking NPBLs before excisional biopsy is to provide
correct localization of the lesion before surgery, to obtain
a clear surgical margin, and to provide the best cosmetic
outcome with minimum tissue loss (12–14). Since the risk
for malignancy is particularly high for BIRADS-4 and -5
lesions detected on mammography and US, this group of
patients is recommended to undergo excisional biopsy
following localization. For this purpose, preoperative
detection of NPBLs includes various methods such as
intraoperative US, localization of the corresponding
skin projection, intralesional localization, and marking
by wire and carbon particles (15,16). Today, WGL is the
most commonly used method for preoperative marking
of NPBLs (12,13,15,17). The ROLL method, an alternative
method that has begun to be used for the marking of
NPBLs in recent years, has been defined as a simple, rapid,
reliable, and comfortable method (12,18–20).
Hybrid methods such as SPECT-CT enable both
metabolic and anatomic scanning. Thus, it is possible to
identify anatomic localization of the lesion by CT, which

has been detected scintigraphically. There are studies
in the literature showing that SPECT-CT is superior to
planar scintigraphy in detecting the sentinel lymph node
in breast cancer patients (21). In the present study, which
compared the WGL method with ROLL and investigated
the additional contribution of SPECT-CT to localization of
the lesion, patients in both groups were similar in terms of
age, BMI, scanning method, and distribution of BIRADS
category. Similarity of both groups in terms of general
patient characteristics and radiological findings indicated
that the groups were comparable.
It is recommended that suspicious lesions detected
by scanning methods should be marked under
mammographic guidance if they are microcalcification
and under US guidance if they are solid lesions or complex
cysts (19). Marking under mammographic or US guidance
should be preferred based on the type of the method
previously used in the diagnosis of the suspicious lesion
(15). In the present study, marking methods were selected
by the radiologists in line with these principles.
In the present study, pathology of one (25%) of 4
lesions in the BIRADS-3 category in the ROLL group
was malignant. The positive predictive value (PPV) for
malignancy in the lesions in the BIRADS-3 category has
been reported between 5% and 14% (22). Higher levels in
the present study might have resulted from a lower number
of patients (n = 4) in the BIRADS-3 category. Pathology
of none of BIRADS-4 lesions in the ROLL group was
malignant. Likelihood of malignancy in this group, which
is more heterogeneous as compared to other groups,
shows a substantially wide range. Therefore, it was divided
into 4a, 4b, and 4c subgroups by the American College of
Radiology. PPV for malignancy in these subgroups is 6%,
15%, and 53%, respectively (23). However, subgroups of
the lesions reported as BIRADS-4 in our center were not
defined. Thus, the subgroup of malignancy [low (4a) or
high (4c)] of the patients in the BIRADS-4 category was
not known. Absence of malignant cases in BIRADS-4
lesions of the ROLL group suggested that these lesions
were probably in the low group (not mentioned in the
pathology report). In the present study, rates of malignancy
(66.6%) detected in BIRADS-5 lesions in both groups were
consistent with the literature. PPV for the malignancy in
this category has been reported as 44%–68% (22).
The present study found that pain during the marking
procedure, which was assessed by VAS, was less in the
ROLL group compared to that in the WGL group (2.0 ±
0.81 vs. 2.61 ± 0.67, P = 0.037). Similarly, in the studies
by Moreno et al. (20) and Rampaul et al. (24), pain sense,
which was evaluated by VAS, was reported to be less in the
ROLL group as compared to that in the wire group. This
can be explained by the marking duration being longer in
the wire group compared to the ROLL group and difficult
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proceeding of the wire in breast parenchyma in those with
dense breast tissue.
In the present study, the mean excision duration of the
lesion was 12.61 ± 4.57 min in the ROLL group and 13.90 ±
4.72 in the WGL group. However, there was no significant
difference between the groups (P = 0.433). Similarly,
studies in the literature have reported shorter excision
duration in the ROLL group than the wire group and no
significant difference between the groups (16,18–20,24,25).
Following the wire in the parenchyma between the place
where the wire is inserted into the skin and the suspicious
lesion takes time. However, the ROLL technique enables a
shorter excision duration with the assistance of the gamma
probe. It is expected that excision duration would be much
shorter along with the surgeons in our center becoming
accustomed to using the ROLL technique and performing
the technique for higher numbers of patients.
The mean weight of the specimens was 49.7 g (range:
6-153 g) in the ROLL group and 39.6 g (range: 5-67 g) in
the WGL group, with no significant difference between the
groups (P = 0.260). There are many studies in the literature
reporting that specimen weight is less in the WGL method
than the ROLL method. Weight of specimens in these
studies has ranged between 14 g and 48 g in ROLL groups
and 28 g and 53 g in wire groups (12,13,16,25–30). Mariscal
Martínez et al. (18) reported that the mean specimen
weight was minimally higher in the ROLL group (68.1 g)
as compared to that in the wire group (67.3 g). Likewise,
Rampaul et al. (24) reported the mean specimen weight as
34 g in the ROLL group and 31 g in the wire group. In the
present study, wider tissue excision in the ROLL group was
attributed to the surgeons keeping the safety margin wider
due to the ROLL method’s being used for the first time in
our center. Surgeons in our center perform a wide excision
approximately 3 cm in diameter including the intact tissue
up to the fascia of the pectoral muscle in such a way that
the area with maximum gamma probe count should be in
the center. There are different opinions in the literature
about excision margins. The common application reported
the excision margin to be the area where the gamma probe
count shows a sharp decrease (19,20,31,32). However,
there are studies reporting that the lesions should be
excised including 1 cm or 2 cm of intact tissue around the
point with the maximum count (12,24,33).
The present study found the rate of positive surgical
margin to be 33.3% in the ROLL group and 42.8% in the
WGL group. Although the rate of positive surgical margin
was lower in the ROLL group, there was no significant
difference between the groups (P = 0.343). Consistent with
the present results, studies in the literature have reported
lower rates of positive surgical margins with the ROLL
method. Studies have found the prevalence of involvement
of surgical margin between 11% and 40% in ROLL groups
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and 32% and 50% in wire groups (13,15,16,19,20,25,27,28).
There are studies reporting that positive surgical margin
was associated with tumor size and tumor histology. A
positive surgical margin is more common in large tumors
with the histology of ductal carcinoma in situ (DCIS) or
lobular carcinoma in situ (LCIS) (29,34). Consistent with
the literature, in both groups of the present study, surgical
margins were positive in the patients with larger tumors
and with DCIS and LCIS pathology.
Although the mean diameter of malignant lesions was
higher in the ROLL group compared to the WGL group
(2.23 ± 1.79 cm vs. 1.77 ± 1.69) in the present study, no
significant difference was found between the groups (P >
0.758). Studies comparing tumor sizes have reported mean
tumor diameter to be between 1.2 cm and 1.5 cm in ROLL
groups and 0.9 cm and 2.5 cm in wire groups (27,32,35).
In the present study, the duration of hospital stay was
remarkably lower in the ROLL group than in the WGL
group, though the difference was not significant (290 ±
374 vs. 640 ± 1267, P = 0.611). This was due to the fact that
higher complication rates in the WGL group prolonged
the duration of hospital stay in this group. Likewise, it was
reported in the literature that duration of hospital stay is
shorter in ROLL group patients as compared to wire group
patients. This can be explained by general anesthesia given
to the patients in the wire group and high complication
rates in this group (19,20,30).
In the present study, 8% of patients in the ROLL
group and 45% of patients in the WGL group developed
complications. Complications such as vasovagal syncope,
broken wire, displaced wire, pain, pneumothorax, and
bleeding (19,36,37) and unsuccessfulness rate reaching
up to 17.9% have been reported in wire groups (38).
Disadvantages of the ROLL method include radioactivity
passage into the duct, injection of radioactivity into the
wrong place, skin contamination, and problems due to
multidisciplinary work (17). If the radioactive agent passes
into the duct, the image of the subsequent injected contrast
agent’s dispersing into the ductal tree draws attention (39).
Sajid et al. (28) compared the ROLL and wire methods in
their metaanalysis consisting of 4 studies and reported that
neither of the groups had major complication; although
the complication rate was higher in the wire group, no
significant difference was found between the groups. In
the present study, the complication rate was significantly
higher in the WGL group as compared to the ROLL group
(8% vs. 45.5%, P = 0.018).
Although cosmetic outcomes at the postoperative
1st and 6th months were better in the ROLL group, no
significant difference was found between the groups. This
might have resulted from the fact that some patients in
the WGL group underwent a second surgery due to high
complication rates. Similar with the present study, studies
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in the literature have revealed better cosmetic outcomes in
ROLL groups because of wider excision (removal of larger
intact tissue) in wire groups and availability of esthetic
skin incision in ROLL groups (16,19,27,29,30).
Evaluation using the criteria during the marking
procedure revealed that suspicious lesions were
successfully marked at a rate of 95.6% in the ROLL group
and 100% in the WGL group. The rate of correct marking
on planar scintigraphy of the patients in the ROLL group
taken after injection was 96% (24/25). Moreover, the rate
of radioactivity on specimen graphs of the lesions was
95.6% (22/23). No activity was observed on the specimen
scintigraphy of a patient for whom the radioactive agent
was left in the injector. Presence of a suspicious lesion was
verified by specimen graphs in 100% (12/12) of the ROLL
group patients that underwent mammography-guided
marking and in 100% (4/4) of the WGL group patients.
These findings supported the hypothesis that suspicious
lesions could be successfully observed by the ROLL
method. Despite the presence of different verification
methods used in the literature to assess the success rate,
success rate changes between 89% and 100% for both
methods (19,24,25,32).
In the present study, SPECT-CT was able to be
performed in only 12 patients due to technical reasons.
SPECT-CT imaging provided additional information
about the localization of the lesions in a patient with
suspicious lesions close to each other in the same breast
(left) and about the deepness of the lesion in 3 patients with
deeply localized lesions. Thus, SPECT-CT imaging made
a contribution to the excision of the lesion in 4 (33.3%)
patients. To the best of our knowledge, no study was found
in the literature about the contribution of SPECT-CT to
the ROLL method in cases of suspicious breast lesions. We
suggest that SPECT-CT scans may contribute to excision of
lesion in selected cases, particularly in those having more

than one suspicious and deeply localized lesion (primary
lesion or lymph node).
Clinical trials are usually performed to show the efficacy
of a new method or an existing method. In such studies the
main restriction is usually the number of patients accepted
to be involved in the new trial. Such prospective studies
including diseases of a specific group like one sex has
to be performed over a long time period for a desirable
number of patients, like in our study. We are of the opinion
that studies conducted on larger numbers of patients are
needed to obtain more detailed and reliable information
about the contributions of SPECT-CT. In the present study
we followed 25 patients in the ROLL group and 11 patients
in WGL group. Both techniques have their own limitations,
e.g., SPECT-CT imaging is required for the ROLL group,
there is a learning curve for both the radiologist and
surgeon in the WGL group, and there is no consensus for
the safety margins during excision of the lesion in both
techniques. During the trials we excluded 8 educational
patients for whom we performed both methods. We think
that the number of patients should be increased to reach
desirable results for the representativeness of the trial, as
well as to reach significant results when comparing the two
methods.
In conclusion, the present study revealed that the
ROLL method was superior to the WGL method in terms
of complication rates, patient comfort (less pain), cosmetic
outcomes, duration of excision, positive surgical margin,
and duration of hospital stay. These results corroborate
the hypothesis that ROLL is a method that can be safely
preferred for marking.
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